BioNTech chief: 'Highly likely' COVID-19 vaccine will hold up against UK coronavirus mutation


BioNTech's chief executive Ugur Sahin told reporters Tuesday it is "highly likely" his company's COVID-19 vaccine, which was developed alongside Pfizer and has been rolled out in several countries including the United States, will hold up against the new coronavirus variant that was first identified in the United Kingdom.
Scientists have many questions about the variant, which appears to be more transmissible, including how it affects vaccine efficacy. Per Reuters, Sahin said he'll need another two weeks of study and data collection to determine whether the Pfizer-BioNTech shot will remain effective, but he is confident the mutations won't be enough to evade the immune response it induces. "The vaccine contains more than 1,270, and only nine of them are changed (in the mutant virus)," Sahin said. "That means 99 percent of the protein is still the same."
Even if an adjustment is required, the mRNA technology used in both the Pfizer-BioNTech and Moderna vaccines would theoretically allow the companies to "engineer a vaccine which completely mimics the new mutation," Sahin said. In that hypothetical scenario it could take just six weeks to produce a new version of the vaccine, though Sahin noted regulators would have to re-evaluate things at that point. Read more at Reuters.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
June 29 editorial cartoons
Cartoons Sunday's political cartoons include the AI genie, Iran saving face, and bad language bombs
-
A tall ship adventure in the Mediterranean
The Week Recommends Sailing aboard this schooner and exploring Portugal, Spain and Monaco is a 'magical' experience
-
How drone warfare works
The Explainer From Ukraine to Iran, it has become clear that unmanned aircraft are rapidly revolutionising modern warfare
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia